Last reviewed · How we verify
Very Low Nicotine Content Cigarettes — Competitive Intelligence Brief
phase 3
Addiction
Small molecule
Live · refreshed every 30 min
Target snapshot
Very Low Nicotine Content Cigarettes (Very Low Nicotine Content Cigarettes) — University of Minnesota. Very Low Nicotine Content Cigarettes work by reducing the amount of nicotine in cigarettes, thereby decreasing the addictive potential and harm associated with smoking.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Very Low Nicotine Content Cigarettes TARGET | Very Low Nicotine Content Cigarettes | University of Minnesota | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Very Low Nicotine Content Cigarettes CI watch — RSS
- Very Low Nicotine Content Cigarettes CI watch — Atom
- Very Low Nicotine Content Cigarettes CI watch — JSON
- Very Low Nicotine Content Cigarettes alone — RSS
Cite this brief
Drug Landscape (2026). Very Low Nicotine Content Cigarettes — Competitive Intelligence Brief. https://druglandscape.com/ci/very-low-nicotine-content-cigarettes. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab